Private#6 of 34 in this industry2 markets

Ennov

en.ennov.com

regulatory information management and submissions software for life sciences (RIMregistrationsIDMPeCTD publishingregulated authoring)
Revenue—not disclosed
Markets named in2across this research
Incumbent in0the one to displace
Rank in industry6 / 34by revenue
01

Where it competes

Every market in this research that names Ennov. Where it is the named incumbent it leads the list. The entry signal is the market’s, not the company’s — it says how open that market is to someone new.

MarketRoleShareEntry signal
Regulatory Information Management & Submissions Software (RIM, eCTD Publishing, Regulated Authoring)
3254 Pharmaceutical and medicine manufacturing
Competitor — 45% entry signal
Pharmacovigilance & Drug Safety Software (Case Intake, Safety Databases, Signal Detection)
3254 Pharmaceutical and medicine manufacturing
Competitor — 32% entry signal
02

Others in Pharmaceutical and medicine manufacturing

Ranked by revenue. Companies that disclose none follow, ordered by how many markets name them.

1 IQVIA NYSE:IQV $6.6B
2 Genpact NYSE:G $5.1B
3 Veeva NYSE:VEEV $3.2B
4 Certara Private $50M
5 ArisGlobal Private —
6 Ennov Private —
7 EXTEDO Private —
8 Oracle Health Private —
9 AcuityMD Private —
10 Adents Private —
11 Antares Vision Private —
12 Axway Private —
13 Cognizant NASDAQ:CTSH —
14 Definitive Healthcare Private —
15 DXC Technology NYSE:DXC —
16 Freyr Solutions Private —
17 Generis Private —
18 Graph AI (Graph Safety) Private —
19 Kivo Private —
20 Komodo Health Private —
21 Körber Private —
22 LORENZ Life Sciences Group Private —
23 LSPedia Private —
24 Movilitas Private —
25 Optel Group Private —

And 9 more — see every company.

Company details are from the search.cos database (snapshot 2026-10-18); market roles, shares and sourced revenue are from the research records linked above. Filed under the industry it serves — a software vendor sits with the industry that buys from it. Ranks convert currencies at approximate rates to put companies in order; every figure shown is in the currency it was reported in.